Heart Disease After Covid: Exacerbated Future Health Risks Aligned to Previous and Existing AAS/Androgen Use

1. AL-HAJJAJ, M., O. ABOU ALAM, M. ALQRALLEH, M. D. ZAKKOR & H. ALMARAWI, 2022. An otherwise healthy male developed COVID-19 disease after the use of anabolic steroid: The second case report. In: Annals of Medicine and Surgery. 82, 104605. DOI: 10.1016/j.amsu.2022.104605.945192836097506 Open DOISearch in Google Scholar

2. ALTHOBAITI, Y. S, M. S. ALZAHRANI, S. M. ALHUMAYANI, S. A. ASSIRY, H. F. ALJUAID & M. A. ALGARNI, 2022. Potential Association between the Use of Anabolic Steroids and COVID-19 Infection. In: Healthcare. 10(2):196. DOI: 10.3390/healthcare10020196.887219135206811 Open DOISearch in Google Scholar

3. BAGGISH, A. L., R. WEINER, G. KANAYAMA, J. HUDSON, M. T. LU, U. HOFFMANN & H. G. POPE, 2017. Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use. In: Circulation. 135:1991–2002. doi: 10.1161/circulationaha.116.026945561451728533317 Open DOISearch in Google Scholar

4. BHANOT A, A. KHANNA, D. RAHUL, D. TALWAR, 2016. Bodybuilders pneumonia. In: Journal of Family Medicine and Primary Care. 5(4), pp. 890–891. DOI: 10.4103/2249-4863.201143535384128349018 Open DOISearch in Google Scholar

5. CADEGIANI F, E. M. LIN, A. GOREN & C. G. WAMBIER, 2021a. Potential risk for developing severe COVID-19 disease among anabolic steroid users. In: BMJ Case Reports. 14:e241572. DOI: 10.1136/bcr-2021-241572791957133637513 Open DOISearch in Google Scholar

6. CADEGIANI, F., J. MCCOY, C. G. WAMBIER & J. R. ADLER, 2021b. Early antiandrogen therapy with dutasteride reduces viral shedding, inflammatory responses, and time-to remission in males with COVID-19: a randomized, double-blind, placebo controlled interventional trial (EAT-DUTA AndroCov Trial-Biochemical). In: Cureus. 13(2): e13047. DOI: 10.7759/cureus.13047788574633643746 Open DOISearch in Google Scholar

7. COHEN, J., R. COLLINS, J. DARKES & D. GWARTNEY, 2007. A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States. In Journal of the International Society of Sports Nutrition. 4(1),pp.1-14. DOI: 10.1186/1550-2783-4-12213175217931410 Open DOISearch in Google Scholar

8. CORONAVIRUS.DATA.GOV.UK, 2022. Official Coronavirus (COVID-19) disease situation dashboard with latest data in the UK. available from: https://coronavirus.data.gov.uk/details/deaths Search in Google Scholar

9. CRISP, P. & J. SIMS, 2020a. Towards A Natural for Life Movement in Sport: Health Implications, Cheating, And Why Anabolic Steroid Users Should Be Banned for Life. In: Biomedical Journal of Scientific & Technical Research. 24(4), 18368-18370. DOI: 10.26717/BJSTR.2020.24.004070. Open DOISearch in Google Scholar

10. CRISP, P. & J. SIMS, 2020b. COVID-19 and anabolic-androgenic steroids (AAS) as immunosuppresors: is it time to revisit government policy and governance arrangements on AAS? In: Archives of Sports Medicine. 4:pp, 245–246. DOI: 10.36959/987/260. Open DOISearch in Google Scholar

11. CRISP, P. & J. SIMS, 2021. Public health concerns and increased risk of severe COVID-19 disease through androgen use. In: Current Opinion in Endocrinology, Diabetes and Obesity. 28(5), pp. 625-629. DOI: 10.1097/MED.0000000000000674.857731134545841 Open DOISearch in Google Scholar

12. CRISP, P. & J. SIMS, 2022. Covid-19, public health strategies and post pandemic aas/androgen use: a commentary/short communication. In: Acta Facultatis Educationis Physicae Universitatis Comenianae. 62(1), pp.1-7. DOI: 10.2478/afepuc-2022-0001 Open DOISearch in Google Scholar

13. ISMAIL, T. F., P. J. ANGELL, A JABBOUR, et al., 2012. Cardiac effects of anabolic steroid use amongst recreational body builders - a CMR study. In: Journal of Cardiovascular Magnetic Resonance. 14:186. DOI: 10.1186/1532-429X-14-S1-P186 Open DOISearch in Google Scholar

14. MAYER, K.N, D. WYDER, D. SPASIC & T. HERREN, 2016. Severe rhinovirus pneumonia in a young woman taking performance-enhancing drugs. In: British Medical Journal Case Reports. bcr2015213836. DOI:10.1136/bcr-2015-213836471636726740273 Open DOISearch in Google Scholar

15. NHS, 2022. Long-term effects of coronavirus (long COVID). Accessible from: https://www.nhs.uk/conditions/coronavirus-covid-19/long-term-effects-of-coronavirus-long-covid/ Search in Google Scholar

16. ONS, 2020. Drug misuse in England and Wales: year ending March 2020. An overview of the extent and trends of illicit drug use for the year ending March 2020. Accessible from: https://www.ons.gov.uk/peoplepopulationandcommunity/crimeandjustice/articles/drugmisuseinenglandandwales/yearendingmarch2020 Search in Google Scholar

17. ONS, 2022a. How Coronavirus (COVID-19) compares with flu and pneumonia as a cause of death. Accessible from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/howcoronaviruscovid19compareswithfluasacauseofdeath/2022-05-23 Search in Google Scholar

18. ONS, 2022b. Coronavirus (COVID-19) latest insights: Hospitals. Accessible from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/hospitals Search in Google Scholar

19. PÄRSSINEN, M., U. KUJALA, E. VARTIAINEN, S. SARNA & T SEPPÄLÄ, 2000. Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. In: International Journal of Sports Medicine. 21(3), pp. 225-7. DOI: 10.1055/s-2000-304.10834358 Open DOISearch in Google Scholar

20. SAGOE D., H. MOLDE, C. S. ANDREASSEN, T. TORSHEIM & S. PALLESEN, 2014. The global epidemiology of anabolic-androgenic steroid use: A meta-analysis and meta-regression analysis. In: Annals of Epidemiology. 24. pp,383–398. DOI: 10.1016/j.annepidem.2014.01.009.24582699 Open DOISearch in Google Scholar

21. SAMAHA, A. A., W. NASSER-EDDINE, E. SHATILA, J. J. HADDAD, J. WAZNE & A. H. EID, 2008. Multiorgan damage induced by anabolic steroid supplements: a case report and literature review. In: Journal of Medical Case Reports. 2, 340. DOI: 10.1186/1752-1947-2-340259616218976461 Open DOISearch in Google Scholar

22. SAUDAN C, N. BAUME, N. ROBINSON, L. AVOIS, P. MANGIN & M. SAUGY, 2006. Testosterone and doping control. In: British Journal of Sports Medicine. 40(1). pp. 121-124. DOI: 10.1136/bjsm.2006.027482.265749516799097 Open DOISearch in Google Scholar

23. SEEAR, K., S. FRASER, D. MOORE & D. MURPHY, 2015. Understanding and responding to anabolic steroid injecting and hepatitis C risk in Australia: A research agenda. In: Drugs: Education, Prevention and Policy. (22)5, pp.449-455. DOI: 10.3109/09687637.2015.1061975 Open DOISearch in Google Scholar

24. SIDIK, S. M., 2022. Heart disease after COVID: what the data say. In: Nature. 608, pp. 26-28. DOI: 10.1038/d41586-022-02074-335918523 Open DOISearch in Google Scholar

25. VAN AMSTERDAM, J., A. OPPERHUIZEN & F. HARTGENS, 2010. Adverse health effects of anabolic–androgenic steroids. In: Regulatory Toxicology and Pharmacology. 57(1), pp. 117-123. DOI: 10.1016/j.yrtph.2010.02.001.20153798 Open DOISearch in Google Scholar

26. WHO, 2021. Emergencies preparedness, response: novel coronavirus – China. 2020. Accessible from: https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/. Search in Google Scholar

27. WHO, 2022. WHO Coronavirus (COVID-19) Dashboard [cit. 2022-09-30]. Accessible from: https://covid19.who.int/ Search in Google Scholar

28. WOOD, R. L., 2008. Anabolic–androgenic steroid dependence? Insights from animals and human. In: Frontiers in Neuroendocrinology. (29)4, pp.490-506. DOI: 10.1016/j.yfrne.2007.12.002258537518275992 Open DOISearch in Google Scholar